AnswersNow Raises $40 Million to Scale AI-Driven Virtual Autism Therapy Platform

New updates have been reported about AnswersNow.

AnswersNow has secured $40 million in Series B financing to accelerate the expansion of its AI-enabled virtual Applied Behavioral Analysis (ABA) therapy platform for children with autism, positioning the company for aggressive growth in a high-demand, capacity-constrained market. The round was led by HealthQuest Capital with participation from existing backers including Left Lane Capital and Owl Ventures, and will fund a planned doubling of AnswersNow’s clinical staff, key leadership hires, and the rollout of new service lines aimed at payors and families. Management intends to deepen investment in its proprietary AI infrastructure, which tailors therapy modules to each child’s interests and engagement patterns, and underpins a care model that uses PhD- and master’s-level Board-Certified Behavioral Analysts (BCBAs) to deliver parent-mediated virtual therapy in a fraction of the hours required by traditional in-person ABA.

For payors and systems under cost pressure, the company is positioning its approach as a structural cost-efficiency play, citing outcomes comparable or superior to conventional ABA while using roughly one-sixth the therapy hours, with up to 75% lower costs for insurers and Medicaid plans. In 2025, AnswersNow delivered nearly 100,000 hours of virtual therapy and caregiver training, and plans to publish research in early 2026 to validate its reported gains in metrics such as Vineland scores over six months of treatment. Executives argue that the model directly addresses systemic access issues in U.S. autism care—where families often wait months for lower-credentialed providers—by connecting families with BCBAs within days and making intensive, personalized therapy financially sustainable at scale. The fresh capital and supporting clinical data are expected to strengthen AnswersNow’s negotiating position with commercial insurers and Medicaid programs, support multistate expansion, and consolidate its role as a specialized, tech-enabled autism care platform in a rapidly growing and underserved market.